Advances in Chronic Kidney Disease
Volume 12, Issue 3 , Pages 300-311, July 2005

Legal Issues in Caring for Patients With Kidney Disease by Selectively Integrating Complementary Therapies

  • Michael H. Cohen

      Affiliations

    • Corresponding Author InformationAddress correspondence to Michael H. Cohen, JD, Harvard Medical School Osher Institute, 401 Park Drive, 22-W, Boston, MA 02215.

Department of Medicine, Harvard Medical School, Boston, MA

Clinical integration of complementary and alternative medical (CAM) therapies, such as acupuncture and traditional oriental medicine, chiropractic, herbal medicine, massage therapy, and “mind-body” therapies, into conventional health care raises important legal and risk management issues. Understanding which CAM therapies patients use is legally prudent, as conventional treatment advice may interact with patients’ own efforts toward self-care. In addition, nephrologists may limit potential liability for medical malpractice by classifying any given therapy as follows: (1) the medical evidence supports both safety and efficacy—recommend; (2) the medical evidence supports safety, but evidence regarding efficacy is inconclusive—accept but monitor; (3) the medical evidence supports efficacy, but evidence regarding safety is inconclusive—accept but monitor; and (4) the medical evidence indicates either serious risk or inefficacy—avoid and discourage. Applying this framework whether a therapy is labeled “conventional” or “CAM” is consistent with the key recommendation of the recent report by the Institute of Medicine at the National Academy of Sciences on Complementary and Alternative Medicine, namely, to apply the same principles and standards of evidence of treatment effectiveness to all treatments. Liability risk management also includes going beyond legal and ethical informed consent requirements by engaging the patient in shared decision making concerning all material treatment options, including CAM therapies, if supported by evidence. Physicians further should familiarize themselves with documentation standards suggested by the Federation of State Medical Board Guidelines and whether these are applicable in their state or home institution. These steps aim to enable nephrologists to respond to patient interest in CAM therapies in a way that is clinically responsible, ethically appropriate, and legally defensible.

Index Words:  Liability, medical malpractice, informed consent, complementary and alternative medicine, kidney disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants from the Greenwall Foundation and the Rudolph Steiner Foundation.

PII: S1548-5595(05)00069-8

doi:10.1016/j.ackd.2005.03.003

Advances in Chronic Kidney Disease
Volume 12, Issue 3 , Pages 300-311, July 2005